Multiple Tumours

Gene: FANCM

Red List (low evidence)

FANCM (Fanconi anemia complementation group M)
EnsemblGeneIds (GRCh38): ENSG00000187790
EnsemblGeneIds (GRCh37): ENSG00000187790
OMIM: 609644, Gene2Phenotype
FANCM is in 20 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

Publication PMID: 28837162 entitled: “Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.” In this study breast cancer probands were investigated for DNA damage response genes, and 5 cases had FANCM loss-of-function variants. They showed a heterogeneous phenotype including cancer predisposition, toxicity to chemotherapy, early menopause, and possibly chromosome fragility. The phenotype severity might correlate with mutation position in the gene. They authors conclude: “Our data indicate that biallelic FANCM mutations do not cause classical FA, providing proof that FANCM is not a canonical FA gene. Moreover, our observations support previous findings suggesting that FANCM is a breast cancer-predisposing gene. Mutation testing of FANCM might be considered for individuals with the above-described clinical features.”
Created: 2 Nov 2017, 2:26 p.m.
This gene is on the UKGTN Hereditary Cancers 82 Gene Panel.
Created: 18 Apr 2017, 1:34 p.m.
Information from TruSight panel: Pathogenic Mutations are Inactivating.
Created: 5 Feb 2016, 11:46 a.m.

Publications

Rebecca Foulger (Genomics England curator)

Comment on list classification: Changed rating of FANCM from Green to Red based on 2009 evidence that reclassifies earlier (2005) FA-M patient as FA-A.
Created: 28 Feb 2017, 1:59 p.m.
Further evidence that FANCM is not a Fanconi Anaemia gene comes from PMID:25078778: in a large exome-sequencing study and study of hospital records Lim et al., 2014 (PMID:25078778) did NOT find evidence to support FANCM as a gene associated with Fanconi Anaemia.
Created: 28 Feb 2017, 1:58 p.m.
FANCM was named as a Fanconi anemia gene based on Meetei et al., 2005 (PMID:16116422) who identified FANCM compound heterozygous variants in a cell line derived from a patient (EUFA867) with FA. They report that the patient's brother (also suffering from FA) carried the identical mutations in his blood DNA.

However, Singh et al., 2009 (PMID:19423727) found that patient EUFA867 also carries biallelic mutations in FANCA. Singh also noted that the FA-affected brother of EUFA867 carried the same biallelic FANCA variants, but only carried one of the FANCM variants, and thus they reclassified the sibling as being an FA-A patient.
Created: 28 Feb 2017, 1:58 p.m.

History Filter Activity

18 Apr 2017, Gel status: 1

Upload gene information

Ellen McDonagh (Genomics England Curator)

FANCM was added to Multiple Tumourspanel. Sources: UKGTN

28 Feb 2017, Gel status: 1

Gene classified by Genomics England curator

Rebecca Foulger (Genomics England curator)

This gene has been classified as Red List (Low Evidence).

28 Feb 2017, Gel status: 4

Set publications

Rebecca Foulger (Genomics England curator)

Publications for FANCM were set to 16116422; 19423727; 25078778

9 Mar 2016, Gel status: 4

Added New Source

Ellen McDonagh (Genomics England Curator)

FANCM was added to Multiple Tumourspanel. Source: Expert Review Green

5 Feb 2016, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

FANCM was created by ellenmcdonagh

5 Feb 2016, Gel status: 0

Added New Source

Ellen McDonagh (Genomics England Curator)

FANCM was added to Multiple Tumourspanel. Sources: TruSight Cancer Panel (Illumina)